RetinalGenix Technologies (RTGN) Invested Capital (2021 - 2025)
RetinalGenix Technologies (RTGN) reported Invested Capital of $49000.0 for Q4 2025, little changed on a YoY basis from $49000.0 in Q4 2024, and little changed sequentially from $49000.0 in Q3 2025.
RetinalGenix Technologies (RTGN) Invested Capital (2021 - 2025) Analysis & Trends
RetinalGenix Technologies (RTGN) has 5 years of Invested Capital data on file, last reported at $49000.0 in Q4 2025.
- For the quarter ending Q4 2025, Invested Capital changed 0.0% year-over-year to $49000.0; the trailing twelve-month figure through Mar 2026 stood at $147000.0 (down 25.0% YoY), and the FY2025 full-year result was $49000.0, changed 0.0% from the prior year.
- Invested Capital steadied at $49000.0 in Q4 2025, from $49000.0 in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $164233.0 in Q3 2021 to a low of $48000.0 in Q3 2022.
- A 5-year average of $59954.9 and a median of $49000.0 in 2022 frame the typical range for Invested Capital.
- Across the five-year window, Invested Capital tumbled 70.77% in 2022 and changed 0.0% in 2023, its largest moves.
- Tracing RTGN's Invested Capital over 5 years: stood at $73000.0 in 2021, then plunged by 32.88% to $49000.0 in 2022, then changed by 0.0% to $49000.0 in 2023, then changed by 0.0% to $49000.0 in 2024, then changed by 0.0% to $49000.0 in 2025.
- Business Quant data shows RTGN's Invested Capital at $49000.0 in Q4 2025, $49000.0 in Q3 2025, and $49000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 4.41 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 499.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.79 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 1.41 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 7.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 15.00 Mn |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 49,000.00 |
| Sep 30, 2025 | 49,000.00 |
| Jun 30, 2025 | 49,000.00 |
| Mar 31, 2025 | 49,000.00 |
| Dec 31, 2024 | 49,000.00 |
| Sep 30, 2024 | 49,000.00 |
| Jun 30, 2024 | 49,000.00 |
| Mar 31, 2024 | 49,000.00 |
| Dec 31, 2023 | 49,000.00 |
| Jun 30, 2023 | 49,000.00 |
| Mar 31, 2023 | 49,000.00 |
| Dec 31, 2022 | 49,000.00 |
| Sep 30, 2022 | 48,000.00 |
| Jun 30, 2022 | 73,000.00 |
| Mar 31, 2022 | 73,000.00 |
| Dec 31, 2021 | 73,000.00 |
| Sep 30, 2021 | 164,233.00 |